Related Experiment Video
Updated: Dec 25, 2025
12:10
Chondrogenic Pellet Formation from Cord Blood-derived Induced Pluripotent Stem Cells
Published on: June 19, 2017
11.4K
Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration?
Damla Alkaya1, Cansu Gurcan1, Pelin Kilic1
11Ankara University Stem Cell Institute, Cevizlidere Mah., Ceyhun Atuf Kansu Cd. No: 169, Balgat, 06520 Ankara, Turkey.
3 Biotech
|March 25, 2020
Summary
Cellular therapies show promise for cartilage repair, but challenges in chondrocyte expansion and differentiation remain. This study reviews chondrocyte-based applications for joint regeneration, highlighting current limitations and future directions.
Area of Science:
- Regenerative Medicine
- Biomedical Engineering
- Orthopedics
Background:
- Cellular-based cartilage therapies are advancing for joint repair.
- Chondrocytes are key for bioengineered cartilage, but face challenges like proliferation and dedifferentiation.
Purpose of the Study:
- To review the practical significance of chondrocyte-based clinical applications in cartilage repair.
- To discuss hurdles in chondrocyte-based cartilage bioengineering and explore alternative approaches.
Main Methods:
- Review of current literature on chondrocyte-based cartilage repair.
- Analysis of challenges in cell sourcing, expansion, and differentiation.
- Exploration of alternative strategies like gene therapy and stem cells.
Main Results:
- Chondrocytes are central to cartilage bioengineering but present limitations.
- Current methods improve joint function but don't fully restore cartilage structure.
- Gene therapy, stem cells, and tissue engineering are emerging trends.
Conclusions:
- Chondrocyte-based therapies require further research to overcome limitations.
- Developing effective biomaterials and culturing conditions is crucial.
- Future strategies may involve combining chondrocytes with other regenerative approaches.
